4-(3-Chloropropyl)morpholine CAS 7357-67-7 Gefitinib Intermediate Purity >98,0% (GC)
Ruifu Chemical minangka produsen utama 4-(3-Chloropropyl)morpholine (CAS: 7357-67-7) kanthi kualitas dhuwur, perantara Gefitinib (CAS: 184475-35-2).Ruifu Chemical bisa nyedhiyakake pangiriman ing saindenging jagad, rega sing kompetitif, layanan sing apik, jumlah cilik lan akeh sing kasedhiya.Tuku 4-(3-Chloropropyl)morpholine,Please contact: alvin@ruifuchem.com
Jeneng Kimia | 4-(3-Kloropropil)morfolin |
sinonim | N-(3-Kloropropil)morfolin;3-Morpholinopropyl Chloride;1-Chloro-3-(Morpholin-4-yl)propana;1-Chloro-3-Morpholinopropane;3-(Morpholin-4-yl)propil Klorida;3-Chloro-1-(Morpholin-4-yl) propana;Gefitinib Impurity VI |
Status Simpenan | Ing Saham, Produksi Komersial |
Nomer CAS | 7357-67-7 |
Formula Molekul | C7H14ClNO |
Bobot Molekul | 163,65 g / mol |
Titik didih | 115 ℃ / 25mmHg (lit.) |
Titik Flash | 91 ℃ |
Sensitif | Sensitif Udara, Sensitif Panas |
COA & MSDS | kasedhiya |
Sampel | kasedhiya |
asale | Shanghai, China |
Merk | Kimia Ruifu |
barang | Standar Inspeksi | Asil |
Penampilan | Cairan bening ora ana warna nganti kuning cahya | tundhuk |
Kemurnian / Metode Analisis | > 98,0% (GC) | 99,35% |
Banyu dening Karl Fischer | <0,50% | 0,26% |
Maksimum Impurity Tunggal | <0,50% | <0,50% |
Total Impurities | <2.00% | 0,65% |
Indeks bias n20/D | 1.4705~1.4765 | tundhuk |
Kapadhetan (20 ℃) | 1.077~1.081 | tundhuk |
1 H NMR Spektrum | Konsisten karo Struktur | tundhuk |
Kesimpulan | Produk wis diuji lan tundhuk karo spesifikasi sing diwenehake | |
Aplikasi | Penengah Gefitinib (CAS: 184475-35-2) |
Paket:Botol Fluorinated, 25kg / Drum, utawa miturut kabutuhan pelanggan.
Kondisi panyimpenan:Tansah wadhah ditutup kanthi rapet lan simpen ing gudang sing adhem, garing lan duwe ventilasi sing adoh saka bahan sing ora cocog.Nglindhungi saka cahya lan Kelembapan.
Pengiriman:Ngirim menyang donya liwat udhara, dening FedEx / DHL Express.Nyedhiyakake pangiriman sing cepet lan dipercaya.
Carane Tuku?Mangga kontakDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
Pengalaman 15 Taun?Kita duwe luwih saka 15 taun pengalaman ing Pabrik lan ekspor saka sawetara saka sudhut intermediet pharmaceutical kualitas dhuwur utawa bahan kimia nggoleki.
Pasar Utama?Adol menyang pasar domestik, Amerika Utara, Eropa, India, Korea, Jepang, Australia, lsp.
Kaluwihan?Kualitas unggul, rega terjangkau, layanan profesional lan dhukungan teknis, pangiriman cepet.
KualitasJaminan?Sistem kontrol kualitas sing ketat.Peralatan profesional kanggo analisis kalebu NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Sampel?Umume produk nyedhiyakake conto gratis kanggo evaluasi kualitas, biaya pengiriman kudu dibayar dening pelanggan.
Audit Pabrik?Audit pabrik welcome.Mangga nggawe janjian ing advance.
MOQ?Ora MOQ.pesenan cilik ditrima.
Wektu Pangiriman? Yen ing saham, telung dina pangiriman dijamin.
Transportasi?Miturut Express (FedEx, DHL), dening Air, dening Sea.
Dokumen?Sawise layanan sales: COA, MOA, ROS, MSDS, etc.
Sintesis khusus?Bisa nyedhiyakake layanan sintesis khusus sing cocog karo kabutuhan riset sampeyan.
Syarat-syarat pembayaran?Invoice Proforma bakal dikirim dhisik sawise konfirmasi pesenan, dilampirake informasi bank kita.Pembayaran kanthi T / T (Transfer Telex), PayPal, Western Union, lsp.
Kode Resiko
36/37/38 - Iritasi ing mripat, sistem pernapasan lan kulit.
Katrangan safety
S26 - Yen kena mripat, langsung mbilas nganggo banyu akeh lan njaluk saran medis.
S36/37/39 - Nganggo sandhangan protèktif, sarung tangan lan protèktif mripat/pasuryan sing cocog.
RTECS QE0488000
Kelas Bahaya IRRITANT
4-(3-Chloropropyl)morpholine (CAS: 7357-67-7) minangka perantara saka Gefitinib (CAS: 184475-35-2).Gefitinib, minangka obat sing digunakake kanggo kanker payudara, paru-paru, lan kanker liyane, uga dikenal minangka Iressa, reseptor faktor pertumbuhan epidermal selektif (EGFR) tyrosine kinase inhibitor, kanggo perawatan perawatan non-kimia lokal utawa metastatik sadurunge utawa ora cocog kanggo kemoterapi kanker paru-paru sel cilik (NSCLC).Gefitinib minangka obat terapi target anti-tumor khusus sing dikembangake dening AstraZeneca ing Inggris.Iki minangka obat sing ditargetake kanthi molekuler pisanan kanggo perawatan kanker paru-paru non-sel cilik.